0% found this document useful (0 votes)
21 views35 pages

Bronchodilators

Bronchodilators are medications used to relieve bronchospasms in respiratory disorders and include adrenoceptor agonists, antimuscarinic bronchodilators, xanthine derivatives, and leukotriene antagonists. They can have various side effects, such as tremors and tachycardia, and may interact with other drugs, particularly anesthetics. Corticosteroids are also used for asthma management, suppressing inflammation and increasing beta2 receptor responsiveness.

Uploaded by

qazicamp2.5
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
21 views35 pages

Bronchodilators

Bronchodilators are medications used to relieve bronchospasms in respiratory disorders and include adrenoceptor agonists, antimuscarinic bronchodilators, xanthine derivatives, and leukotriene antagonists. They can have various side effects, such as tremors and tachycardia, and may interact with other drugs, particularly anesthetics. Corticosteroids are also used for asthma management, suppressing inflammation and increasing beta2 receptor responsiveness.

Uploaded by

qazicamp2.5
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 35

BRONCHODILATORS

Bronchodilators
• Drugs used to relieve bronchospasms associated with
respiratory disorders
• Includes:
– Adrenoceptor agonists
• Selective β2-agonists & other adrenoceptor
agonists
– Antimuscarinic bronchodilators
– Xanthine derivatives
– Leukotriene antagonist

2
• Adrenoceptor agonists
– (i) Selective beta2 agonists
• Stimulate beta2 receptors in smooth muscle of
the lung, promoting bronchodilation, and
thereby relieving bronchospasms

4
Short-acting β-2 agonists

Drug Formulation Dosage


Adult Child
Salbutamol Oral tablet 8 mg twice daily 4 mg twice daily

Inhaler (MDI), 100mcg/dose 100-200mcg up to three to Same as adult


four times daily
Syrup, 2mg/5ml 4 mg three to four times 1-2 mg three to four times
daily daily (≥2 yr)
Terbutaline Oral tablet (S.R) 5-7.5 mg two times daily -
Inhaler 500mg / dose 500 mcg up to four times -
( Turbuhaler) daily

Inhaler 250mg / dose (MDI) 250-500mcg up to 3-4 times Same as adult


daily, .04mg/kg sc

6
Long-acting β-2 agonists
Drug Formulation Dosage

Adult Child

Formoterol Inhaler 4.5mcg / dose 4.5-9 mcg once or twice Same as adult
(Turbuhaer) daily

Inhaler 9mcg / dose


(Turbuhaer)

Salmeterol Inhaler 25mcg / dose 50-100 mcg twice daily Same as adult
(MDI)

50 mcg / dose (Accuhaler) 50 mcg twice Same as adult

7
SIDE EFFECTS OF β2 AGONISTS

• Tremor (β2-receptors in skeletal muscles)


• Tachycardia (reflex tachycardia and direct stimulation
of β2-receptors in the heart)
• Transient decrease in arterial oxygenation (relaxation
of compensatory pulmonary vascular
vasoconstriction in areas of decreased ventilation)
• Acute metabolic responses (hyperglycemia,
hypokalemia, hypomagnesemia, not present with
chronic treatment)
• Lactic acidosis
Drug-Drug Interactions
– (ii) Other adrenoceptor agonists
• Less suitable & less safe for use as bronchodilators
because they are more likely to cause arrhythmias .

• Adrenaline (epinephrine) injection is used in the


emergency treatment of acute allergic and
anaphylactic reactions

12
• Antimuscarinic bronchodilators
– Blocks the action of acetylcholine in bronchial
smooth muscle, this reduces intracellular GMP, a
bronchoconstrictive substances.
– Used for maintenance therapy of
bronchoconstriction associated with chronic
bronchitis & emphysema

13
Drug Formulation Dosage

Adult Child

Ipratropium Inhaler 20 mcg / dose 20-80 mcg three to four 20-40 mcg three to four
(MDI) times a day times a day (≥6yrs)

Tiotropium Inhaler 18 mcg /dose 18 mcg daily Not recommended in


children and adolescents

14
• Adverse effects:
– Dry mouth
– Nausea
– Constipation
– Headache

15
Combination Therapy
• Ipratropium+albuterol (DuoNeb®, generic)
[0.5 mg+3 mg# per 3 ml] 3 ml 6 times per day
• Xanthine Derivatives
– Main xanthine used clinically is theophylline
– Theophylline is a bronchodilator which relaxes smooth
muscle of the bronchi, it is used for reversible airway
obstruction
– One proposed mechanism of action is that it acts by
inhibiting phosphodiesterase, thereby increasing cAMP,
leading to bronchodialtion

17
Drug Formulation Dosage

Adult Child

Theophylline Tablet 200 / 300 mg 200 – 300 mg twice daily 10 mg / kg ((≥2yrs) twice
(S.R.) daily
Capsule 50 / 100 mg 7-12 mg/ kg / day in two divided 10-16 mg / kg / day in two
(Slow release) doses divided doses (9–16yrs)
13-20 mg / kg / day in two
divided doses (30 months – 8
yrs)
Syrup 80 mg / 15 ml 25 ml q6h 1 ml / kg (Max 25 ml) q6h
(≥2yrs)

Aminophylline Injection 25 mg / ml 500 mcg / kg / hr IV infusion, 1 mg / kg /hr (6 months – 9


10 ml adjust when necessary years)
800 mcg / kg /hr (10 – 16 yrs)
IV infusion, adjust when
necessary

18
– Adverse effects:
• Toxicity is related to theophyline levels (usually 5-15
µg/ml)
• 20-25 µg/ml : Nausea, vomiting, diarrhea, insomnia,
restlessness
• >30 µg/ml : Serious adverse effects including
dysrhythmias, convulsions, cardiovascular collapse
which may result in death

20
• Bronchodilators are sympathomimetics and commonly
interact with volatile anesthetics to cause cardiac
arrhythmias.
• Aminophyllin commionly interact with halothane.
• It is advisable to wait 13 hrs(approx 3 half lives)after
the last dose of aminophyllin before using halothane
for an asthmatic patient.
• Use of another anaesthetic (enflurane, isoflurane,
sevoflurane) decreases this problem
• The combination of Theophyllin and ketamine may
predispose the patient to seizures.

21
Corticosteroids

1.Used for prophylaxis of chronic asthma


2.Suppressing inflammation
 Decrease synthesis & release of inflammatory mediators
 Decrease infiltration & activity of inflammatory cells
 Decrease edema of the airway mucosa
3.Decrease airway mucus production
4.Increase the number of bronchial beta2 receptors & their
responsiveness to beta2 agonists

22
Drug Formulation Dosage

Adult Child
Beclomethasone Inhaler 50 mcg / dose 200 mcg twice daily / 50 – 100 mcg two to four
(MDI) 100mcg three to fours times daily
times daily
Up to 800 mcg daily
Inhaler 250 mcg / dose 500 mcg twice daily / 250 Not recommended
(MDI) mcg four times daily

23
Drug (Cont’d) Formulation Dosage
Adult Child
Budesonide Inhaler 50 mcg / dose 200 mcg twice daily 50 – 400 mcg twice
(MDI) Up to 1.6 mg daily daily
Up to 800 mcg daily
Inhaler 200mcg / dose
(MDI)

Inhaler 100 mcg / dose 200-800 mcg once daily 200-800 mcg daily in
(Turbuhaler) in evening two divided doses /
Up to 1.6 mg daily in 200-400 mcg once
two divided doses daily in evening
Inhaler 200 mcg / dose
(<12 yrs)
(Turbuhaler)

Inhaler 400 mcg / dose


(Turbuhaler)

24
Drug (Cont’d) Formulation Dosage

Adult Child

Fluticasone Inhaler 25mcg / dose (MDI) 100 – 1000 mcg 50-100 mcg twice daily
twice daily (4-16 yrs)
Inhaler 50 mcg / dose (MDI)

Inhaler 125 mcg / dose (MDI)


Inhaler 250 mcg / dose (MDI)
Inhaler 50 mcg / dose (Accuhaler)
Inhaler 100 mcg / dose (Accuhaler)
Inhaler 250 mcg / dose (Accuhaler)

25
• Adverse effects
– Inhaled corticosteroids:
• Candidiasis of the mouth or throat
• Hoarseness
• Can slow growth in children
• Adrenal suppression may occur in long-term, high
dose therapy
• Increases the risk of cataracts

26
• Perioperative systemic steriods should be administered
to the patients of bronchial asthma if symptoms persist
and PEFR and FEV1 is less than 80% of predicted.
• HPE suppression should be assumed to be present in
the patients who have received systemic steroid for
more than 3 weeks in the past six months.
• These should receive stress dose coverage( inj Hydrocot
100 mg iv 8 hrly with rapid tapering after 24 hrs.

27
Anaesthetics bronchodilator

• Halothane
• Sevoflurane
• Isoflurane
• Desflurane
• Enflurane
• Propofol
Cromoglycates
• Stabilise mast cells & prevent the release of
bronchoconstrictive & inflammatory substances when
mast cells are confronted with allergens & other stimuli
• Only for prophylaxis of acute asthma attacks

29
Drug Formulation Dosage

Adult Child

Cromoglycate Na Inhaler (1 mg 10 mg four times daily, may be Same as adult


& 5mg/dose) increased to six to eight times
daily

Nebuliser 20 mg four times daily, may be Same as adult


solution 10 mg increased six times daily
/ ml 2 ml

Nedocromil Inhaler 2 mg / 4 mg two to four times daily Sames as adult (>6


Sodium dose (MDI) yrs)

30
Adverse effects

Transient Bronchospasm A selective β2 agonist such as


salbutamol or terbutaline may
be inhaled a few minutes
beforehand

Others: coughing, throat irritation

31
Leukotriene receptor antagonists
• Act by suppressing the effects of leukotrienes,
compounds that promote bronchoconstriction as well
as eosinophil infiltration, mucus productions, & airway
edema
• Help to prevent acute asthma attacks induced by
allergens & other stimuli
• Indicated for long-term treatment of asthma

32
• Dosage:
– Montelukast (5 & 10 mg tablets)
• Adult: 10 mg daily at bedtime
• Child:
– (2-5yrs) 4 mg daily at bedtime
– (6-14yrs) 5 mg daily at bedtime

33
• Adverse effects:
– GI disturbances
– Hypersensitivity reactions
– Restlessness & headache
– Upper respiratory tract infection
– Manufacturer advises to avoid these drugs in
pregnancy & breast-feeding unless essential

34
Thank you

35

You might also like